Stem Cell-Based Clinical Trials for Diabetes Mellitus

Since its introduction more than twenty years ago, intraportal allogeneic cadaveric islet transplantation has been shown to be a promising therapy for patients with Type I Diabetes (T1D). Despite its positive outcome, the impact of islet transplantation has been limited due to a number of confoundin...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 12; p. 631463
Main Authors de Klerk, Eleonora, Hebrok, Matthias
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 26.02.2021
Subjects
Online AccessGet full text

Cover

Loading…